Market capitalization | CHF1.21b |
Enterprise Value | CHF1.37b |
P/E (TTM) P/E ratio | 13.21 |
EV/FCF (TTM) EV/FCF | 11.26 |
P/B ratio (TTM) P/B ratio | 0.73 |
Dividend yield | 4.21% |
Last dividend (FY24) | CHF7.50 |
Revenue (TTM) Revenue | CHF0.00 |
EBIT (operating result TTM) EBIT | CHF-2.56m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
2 Analysts have issued a HBM Healthcare Investments forecast:
2 Analysts have issued a HBM Healthcare Investments forecast:
Sep '24 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -2.56 -2.56 |
32%
32%
|
EBIT (Operating Income) EBIT | -2.56 -2.56 |
32%
32%
|
Net Profit | 92 92 |
150%
150%
|
In millions CHF.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds.
Head office | Switzerland |
CEO | Andreas Wicki |
Founded | 2001 |
Website | www.hbmhealthcare.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.